Clinical Trials for Third-line or Later (3L+) Platinum-resistant Ovarian Cancer (PROC)

Find clinical trials for third-line or later (3l+) platinum-resistant ovarian cancer (proc). Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies

NCT ID: NCT05081609

This clinical trial is testing a new treatment called TransCon IL-2 β/γ, which is being studied for adults with advanced solid tumors that cannot be treated with surgery or radiation. The trial is ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Los Angeles, California, United States, Oklahoma City, Oklahoma, United States +54 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Prostate Cancer View clinical trials → Healthy View clinical trials →

Search All Trials Browse All Conditions